PTC Therapeutics said on Tuesday it is discontinuing the development of its drug for a type of fatal neurodegenerative disease, as it did not meet the main goal in a mid-stage trial.
Click on the article title to read more.
Do Republicans and Democrats have different tastes in chocolate? Researchers explain how people avoid products they think their political opponents enjoy.
Language models are known to hallucinate incorrect information, and it is unclear if they are sufficiently accurate and reliable for use in scientific research. We…
Even as AI gains traction in police work, legal experts are raising concerns over accuracy, transparency, and potential bias.
Researchers report on successful use of mavacamten for hypertrophic cardiomyopathy under the REMS program in a real-world study. Real-world study shows a low rate of…
Walking pneumonia may be milder than traditional pneumonia, but it can still pack a wallop. A pulmonologist explains the differences in causes, symptoms and treatment.
AI can deliver agriculture workers improved efficiency across the board.
Securing the Rhode Island Department of Health’s approval was the final state regulatory hurdle.
The Biden administration is proposing changes to Medicare Advantage plans designed to alleviate coverage barriers
In this Review, Chen and Kim explore the exciting journey of discovering small and long non-coding RNAs. They also explain the current understanding as to…
